Dermatology Roundup: Genetic Link Between GLP-1 Receptor Agonists and Hair Loss
A new study provides the first scientific evidence of a suspected genetic link between the use of GLP-1 receptor agonists and hair loss.
Read More:
Swiss dermatology company Galderma is expanding in Miami, lured by the city’s mix of high-income spenders and a booming plastic surgery industry that attracts visitors from around the world.
Professor of Dermatology and Pathology Christine Ko, MD, has been named president of the American Board of Dermatology (ABD) Board of Directors! In this role, Ko will help lead ABD's efforts to enhance its certification procedures and standards, as well as its overall strategy.
Associate Professor of Dermatology Sara Perkins, MD, and other experts report a correlation between common GLP-1 medications and hair loss. Learn more about why this side effect may occur and how you can take action.
Presenting recently published findings on how dermatology AI tools may help laypeople with their own skin-related questions, such as increased ability to name conditions, & some benefits in determining what next steps to take. Read more →
Bambusa, an early-stage biotech focused on dermatology and autoimmune diseases, has raised $168.9 million in an upsized US initial public offering that priced at the midpoint of its marketed range
🎙️👀 APP-solutely Essential: Putting Corticosteroid Stewardship Into Practice
Corticosteroids remain one of dermatology’s most reliable workhorses, but good stewardship isn’t about putting the horse out to pasture.
Listen Now: